source:[1] Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study, STARt-002, at the 2025 San Antonio Breast Cancer Symposium - BioSpace (https://www.biospace.com/press-releases/maren ...)[2] Amgen Scores Uplizna Expansion Into Generalized Myasthenia Gravis - BioSpace (https://www.biospace.com/fda/amgen-scores-upl ...)[3] Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS - BioSpace (https://www.biospace.com/press-releases/exact ...)